National Survey on Asthma

• Register: ClinicalTrials.gov
• Last refreshed on: 19 February 2015
• Main ID: NCT00770250
• Date of registration: 07/10/2008
• Prospective Registration: No
• Primary sponsor: AstraZeneca
• Public title: National Survey on Asthma SYMPTOMES
• Scientific title: A Mirror Assessment of the Words Used By Patients and Physicians to Express Asthma Symptoms, According To the Patient's Level of Asthma Control In General Medicine
• Date of first enrolment: September 2008
• Target sample size: 1704
• Recruitment status: Completed
• URL: http://clinicaltrials.gov/show/NCT00770250
• Study type: Observational
• Study design: Observational Model: Cohort, Time Perspective: Cross-Sectional
• Phase: N/A

Countries of recruitment

France

Contacts

• Name: Alain Castaigne
• Affiliation: AstraZeneca

Key inclusion & exclusion criteria

Inclusion Criteria:

- A diagnosis of persistent asthma treated with an inhaled corticosteroid based
maintenance treatment for more than 3 months

- Given his/her consent to participate to the study and who is able to answer the
questionnaire in french by him/her-self.

Exclusion Criteria:

- Patient with a cardiac disease (congestive heart failure, coronary artery disease)

- Patient with a respiratory disease other than asthma (COPD, sleep apnea syndrome).



Age minimum: 18 Years
Age maximum: N/A
Gender: Both

Health Condition(s) or Problem(s) studied

Asthma

Primary Outcome(s)

The concordance of the most frequently used words by the patients and the physicians to express asthma symptoms, according to the patient's level of asthma control. [Time Frame: Once]

Secondary ID(s)

NIS-RFR-DUM-2008/1

Source(s) of Monetary Support

Please refer to primary and secondary sponsors